BioSpace News Archive

Artelo Biosciences, Inc. announced that Gregory D. Gorgas, Chief Executive Officer of Artelo has been invited to present at the Spring Into Action - Best Ideas Virtual Investor Conference, which is being held virtually May 16th - 20th, 2022.

Edesa Biotech, Inc. reported financial results for the three and six months ended March 31, 2022 and provided an update on its business.

Biostage, Inc. (OTCQB: BSTG) (“Biostage” or the “Company”), today announced that it has raised approximately $5.1 million from new and existing investors in a private placement of its shares.

RaySearch Laboratories AB releases preliminary figures for the first quarter of 2022. Order intake increases by 88 percent to SEK 273 million, sales increase by 28 percent to SEK 208 million and EBIT amounts to SEK 29 million.

Palisade Bio (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today reported its financial results for the quarter ended March 31, 2022.

ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced it will present investigational research and exhibit at the 25th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) in Washington, DC.

Clearmind Medicine Inc. (CSE: CMND, OTC Pink: CMNDF, FSE: CWY0) (“Clearmind” or the “Company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under treated health problems, today announced that it will meet with the Center for Drug Evaluation and Research (“CDER”) of the U.S. Food and Drug Administration (“FDA”) on Wednesday, May 18, 2022.

The increasing burden of chronic diseases and the growing geriatric population are leading to an increase in the number of prescriptions.

Biobanks hold the future of medical research, diagnostic, and treatments in their data, but it is often hard to make good use of the data for global benefit.

Vytal, a pharmacy service and healthcare technology company, today announced the appointment of Prasanna Parthasarathy as chief executive officer.